Tiverton, RI, United States of America

Moses B I Goddard


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Moses B I Goddard

Introduction

Moses B I Goddard, based in Tiverton, Rhode Island, is a prominent inventor known for his groundbreaking work in the field of cell-based delivery systems. With one patent to his name, Goddard has made significant strides in advancing medical technology, particularly in the realm of encapsulated cell-based therapies.

Latest Patents

Goddard's patent, titled ARPE-19 as a platform cell line for encapsulated cell-based delivery, showcases the versatility and robustness of ARPE-19 cells. These cells are evaluated as a platform for both encapsulated and unencapsulated delivery technologies. The findings indicate that ARPE-19 cells possess several desirable traits: they remain viable under stringent conditions, can be genetically modified to secrete specific proteins, exhibit a long lifespan, originate from human cells, maintain good in vivo device viability, deliver effective quantities of growth factors, trigger minimal host immune reactions, and are non-tumorigenic.

Career Highlights

Goddard is currently affiliated with Neurotech S.A., a company focused on the development of innovative therapies to restore vision and other functionalities using cell-based technologies. His work at Neurotech S.A. emphasizes the potential of leveraging active biological agents for therapeutic advantages.

Collaborations

Throughout his career, Moses B I Goddard has collaborated with notable professionals in the field, including Weng Tao and David H Rein. These partnerships have contributed to further advancements in the research and application of cell-based delivery systems, enhancing the impact of their collective work on medical science.

Conclusion

Moses B I Goddard exemplifies the spirit of innovation in the biotechnological field. His contributions through the patent of ARPE-19 cells signify a leap forward in encapsulated cell-based delivery technologies. With ongoing collaboration and research, Goddard and his colleagues at Neurotech S.A. continue to pave the way for future advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…